Taysha Gene Therapies, Inc.

TSHA

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001806310

SEC filings (opens in a new tab)

In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

Superinvestors holding TSHA, Q2 2026

See all superinvestors

No superinvestor reported holding TSHA in Q2 2026.